Annual Report 2025 - AARTI DRUGSBSE · annual report · 136 pages
VerifiedArchived copy Company dossier
Aarti Drugs
NSE:AARTIDRUGS · ISIN INE767A01016
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Aarti Drugs
Business
Business evidence pack
Source documentsPrimary material for understanding Aarti Drugs
Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.
Annual Report FY 2024-2025 - Aarti Drugs LimitedNSE · annual report · 136 pages
VerifiedArchived copy Financial Year 2025 from bseBSE · annual report · 136 pages
VerifiedArchived copy Financial Year 2024 from bseBSE · annual report · 277 pages
VerifiedArchived copy Financial Year 2023 from bseBSE · annual report · 243 pages
VerifiedArchived copy Annual Report FY 2021-2022 - Aarti Drugs LimitedNSE · annual report · 193 pages
VerifiedArchived copy Financial Year 2022 from bseBSE · annual report · 193 pages
VerifiedArchived copy Financial Year 2021 from bseBSE · annual report · 171 pages
VerifiedArchived copy Financial Year 2020 from bseBSE · annual report · 176 pages
VerifiedArchived copy Financial Year 2019 from bseBSE · annual report · 155 pages
VerifiedArchived copy Financial Year 2018 from bseBSE · annual report · 158 pages
VerifiedArchived copy Annual Report FY 2016-2017 - Aarti Drugs LimitedNSE · annual report · 114 pages
VerifiedArchived copy Annual Report FY 2016-2017 - Aarti Drugs LimitedNSE · annual report · 114 pages
VerifiedArchived copy Financial Year 2017 from bseBSE · annual report · 114 pages
VerifiedArchived copy Annual General Meeting Updates - Aarti Drugs LimitedNSE · annual report · 113 pages
VerifiedArchived copy Annual General Meeting Updates - Aarti Drugs LimitedNSE · annual report · 113 pages
VerifiedArchived copy